HCK and chronic myelogenous leukemia, BCR-ABL1 positive: HCK is involved in immune and inflammatory responses and has been implicated in various leukocyte-related disorders, particularly chronic myelogenous leukemia (CML) and acute myeloid leukemia (AML) (Lowell, 2011).